Cancer – Page 6 – HealthQuill

Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.

Embedded LEDs may aid future cancer immunotherapies

Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.

by HealthQuill
February 18, 2023
0 Comments

GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe type of recall.

Drugs Medical Pharma

GE Healthcare recalls 688 medical systems, FDA says ‘most serious’

GE Healthcare has pulled out 688 medical systems that evaluate diseases, trauma, abnormalities and disorders, a move which USFDA termed a most severe.

by HealthQuill
February 16, 2023
0 Comments

The USFDA has put on hold Blueprint Medicines Corporation's clinical trial of BLU-222 due to visual adverse events seen in some patients, according to a company statement.

Drugs Pharma

FDA puts on hold Blueprint Medicines’ clinical trial for solid cancers

The USFDA has put on hold Blueprint Medicines Corporation's clinical trial of BLU-222 due to visual adverse events seen in some patients, according.

by HealthQuill
February 12, 2023
0 Comments

A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s top research institutes, Karolinska Institutet, wrote in a study.

Drugs Medical Pharma

Blood cancer therapy may help to treat ovarian cancer: Swedish scientists

A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s.

by HealthQuill
February 7, 2023
0 Comments

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA drugs.

Drugs Pharma

BioNTech to invest $43 million in new mRNA facility

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.

by HealthQuill
February 3, 2023
0 Comments

Medical Pharma

BioNTech signs MoU with UK govt to start clinical trials for mRNA cancer vaccine

BioNTech signs MoU with the British government to start mRNA cancer trials

by HealthQuill
January 13, 2023
0 Comments

Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer treatment.

Drugs Pharma

Aurobindo Pharma gets FDA nod for injection to treat cancer

Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.

by HealthQuill
January 4, 2023
0 Comments

Drugs Pharma

Israeli researchers develop artificially intelligent pathological assistants

Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.